This afternoon we watched agilon health inc. drop -2.6% to a price of $16.89 per share. The large-cap Medical Distribution company is now trading -43.47% below its average target price of $29.88. Analysts have set target prices ranging from $22.5 to $41.0 per share for agilon health inc., and have given the stock an average rating of buy.
The stock has an unusually large proportion of its shares sold short at 27.9%, and a short ratio of 6.81. Since 1.09% of the company's shares are owned by insiders, we can infer that there is a degree of alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 106.1% of agilon health inc.'s shares being owned by this investor type.
Institutions Invested in agilon health inc.
Date Reported | Holder | Percentage | Shares | Value |
---|---|---|---|---|
2023-03-31 | Clayton, Dubilier & Rice, LLC | 47% | 194,611,308 | $3,286,984,873 |
2023-03-31 | FMR, LLC | 13% | 54,656,726 | $923,152,068 |
2023-03-31 | Capital World Investors | 10% | 42,435,971 | $716,743,524 |
2023-03-31 | Morgan Stanley | 9% | 36,617,578 | $618,470,870 |
2023-03-31 | Wellington Management Group, LLP | 5% | 20,346,055 | $343,644,856 |
2023-03-31 | Vanguard Group, Inc. (The) | 5% | 19,236,251 | $324,900,267 |
2023-03-31 | Capital Research Global Investors | 3% | 13,043,536 | $220,305,315 |
2023-03-31 | Blackrock Inc. | 2% | 8,721,918 | $147,313,189 |
2023-03-31 | Rock Springs Capital Management, LP | 2% | 7,882,500 | $133,135,420 |
2023-03-31 | Durable Capital Partners Lp | 1% | 5,503,139 | $92,948,014 |
Besides an analyst consensus of strong upside potential, other market factors point to there being mixed market sentiment on agilon health inc..